Head-upright tilt-table testing provides a valuable method for identifying individuals predisposed to neurocardiogenic syncope and guiding potential therapies.
Answers are grounded in this paper and cite their sources.
Supports tilt-table testing in syncope evaluation; leaves open randomized confirmation of therapy guidance.
Recurrent episodes of unexplained syncope are among the most frequent of complaints referred to physicians for evaluation. Traditional methods of evaluation were both time consuming and expensive and left many patients without a diagnosis. Although neurocardiogenically mediated episodes of hypotension and bradycardia were felt to be a common cause of syncope, this was traditionally a diagnosis of exclusion. The emergence of head-upright tilt-table testing has provide a valuable method for identifying individuals predisposed to neurocardiogenic syncope and has also allowed for a better understanding of this phenomena. This article reviews the pathophysiology of neurocardiogenic syncope, the use of head-upright tilt-table testing in its diagnosis, and the potential therapies used to prevent recurrences.
No takes yet. Share an insight, caveat, or question.
Grubb et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: